Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
The quality of immune response to SARS-CoV-2 is thought to wane over time, but it is unclear how long it can persist. Here the authors show persistent immune responses in a large number of patients over the course of a 1-year follow-up from the time of recovery from COVID-19.
Guardado en:
Autores principales: | Chengqian Feng, Jingrong Shi, Qinghong Fan, Yaping Wang, Huang Huang, Fengjuan Chen, Guofang Tang, Youxia Li, Pingchao Li, Jiaojiao Li, Jianping Cui, Liliangzi Guo, Sisi Chen, Mengling Jiang, Liqiang Feng, Ling Chen, Chunliang Lei, Changwen Ke, Xilong Deng, Fengyu Hu, Xiaoping Tang, Feng Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22d27130a2994152b43581a0fb1c8e27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression patterns of genes involved in sugar metabolism and accumulation during apple fruit development.
por: Mingjun Li, et al.
Publicado: (2012) -
MicroRNA-4521 targets hepatoma up-regulated protein (HURP) to inhibit the malignant progression of breast cancer
por: Changwen Li, et al.
Publicado: (2021) -
Combined effects of nano-silica and silica fume on the mechanical behavior of recycled aggregate concrete
por: Yunchao Tang, et al.
Publicado: (2021) -
Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model
por: Wei Yu, et al.
Publicado: (2018) -
Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities
por: Hanagata N, et al.
Publicado: (2017)